Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Ebola virus (EBOV) infection blocks cellular production of alpha/beta interferon (IFN-α/β) and the ability of cells to respond to IFN-α/β or IFN-γ. The EBOV VP35 protein has previously been identified as an EBOV-encoded inhibitor of IFN-α/β production. However, the mechanism by which EBOV infection inhibits responses to IFNs has not previously been defined. Here we demonstrate that the EBOV VP24 protein functions as an inhibitor of IFN-α/β and IFN-γ signaling. Expression of VP24 results in an inhibition of IFN-induced gene expression and an inability of IFNs to induce an antiviral state. The VP24-mediated inhibition of cellular responses to IFNs correlates with the impaired nuclear accumulation of tyrosine-phosphorylated STAT1 (PY-STAT1), a key step in both IFN-α/β and IFN-γ signaling. Consistent with this proposed function for VP24, infection of cells with EBOV also confers a block to the IFN-induced nuclear accumulation of PY-STAT1. Further, VP24 is found to specifically interact with karyopherin α1, the nuclear localization signal receptor for PY-STAT1, but not with karyopherin α2, α3, or α4. Overexpression of VP24 results in a loss of karyopherin α1-PY-STAT1 interaction, indicating that the VP24-karyopherin α1 interaction contributes to the block to IFN signaling. These data suggest that VP24 is likely to be an important virulence determinant that allows EBOV to evade the antiviral effects of IFNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The sequestration of importins in the cytoplasm has been reported for other non-nuclear-replicating viruses, such as Ebola [58], as a means to inhibit interferon signaling.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900 · cited 1×
“(STAT1 is a key transcription factor in the IFN signaling pathways, and its expression is upregulated upon IFN- treatment [15, 37].”
BackgroundInterferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899 · cited 1×
“The nuclear localization of STAT1 (reviewed in references 47 and 49) is triggered by its tyrosine phosphorylation-induced, SH2 domain-dependent dimerization (23, 54, 57, 58).”
BackgroundShuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., & Darnell, J. E. (1994) · Cell · doi:10.1016/0092-8674(94)90357-3 · Cited by 807 · cited 1×
“The nuclear localization of STAT1 (reviewed in references 47 and 49) is triggered by its tyrosine phosphorylation-induced, SH2 domain-dependent dimerization (23, 54, 57, 58).”
BackgroundActivation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775 · cited 1×
“The nuclear localization of STAT1 (reviewed in references 47 and 49) is triggered by its tyrosine phosphorylation-induced, SH2 domain-dependent dimerization (23, 54, 57, 58).”
BackgroundLive attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
Jones, S. M., Feldmann, H., Ströher, U., Geisbert, J. B., Fernando, L., Grolla, A., Klenk, H.-D., Sullivan, N. J., Volchkov, V. E., Fritz, E. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1258 · Cited by 687 · cited 1×
“At present, no vaccines against EBOV are licensed for use in humans, although experimental vaccines that are effective in nonhuman primates have been described (34, 59, 60).”
BackgroundSelf-citationDevelopment of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663 · cited 1×
“At present, no vaccines against EBOV are licensed for use in humans, although experimental vaccines that are effective in nonhuman primates have been described (34, 59, 60).”
BackgroundPathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492 · cited 1×
“The IFN system has been clearly implicated in the susceptibility of mice to EBOV disease (9, 12, 42), and the sequence of VP24, along with that of several other genes, changed following the adaptation, by serial passage, of Zaire EBOV to mice (10).”
BackgroundThe Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478 · cited 13×
“To determine whether VP24 might globally block nuclear import, we determined whether it affected the localization of a GFP–IRF-3 fusion, which accumulates in the nucleus following Sendai virus infection.”
BackgroundMethodInfluentialSelf-citation
Research works printed but not linked: 3
- 10.1128/mcb.9.11.5062-5072.1989 · doi:10.1128/mcb.9.11.5062-5072.1989 · Paper page
- Basler, C. F., and P. Palese. 2004. Modulation of innate immunity by filoviruses, p. 305-349. In H.-D. Klenk and H. Feldmann (ed.), Molecular and cellular biology of Marburg and Ebola viruses. Horizon Scientific Press, Norfolk, United Kingdom.
- Sanchez, A., A. S. Khan, S. R. Zaki, G. J. Nabel, T. G. Ksiazek, and C. J. Peters. 2001. Filoviridae: Marburg and Ebola viruses, p. 1279-1304. In B. N. Fields and D. M. Knipe (ed.), Fields virology, 4th ed., vol. 1. Lippincott Williams and Wilkins, Philadelphia, Pa.
Cited by
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
“However, as with the NS1 protein of influenza A viruses (below), the importance of the dsRNAbinding activity of the VP35 protein of EBOV in blocking IFN induction is not clear (Cardenas et al., 2006; Feng et al., 2007).”
BackgroundInfluentialFeldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Kopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 673
“Ebola virus protein VP35 inhibits interferon by binding and sequestering double-stranded RNA, while VP24 inhibits interferon by preventing the nuclear accumulation of activated STAT1 (1, 18).”
BackgroundCrossing the Nuclear Envelope: Hierarchical Regulation of Nucleocytoplasmic Transport
Terry, L. J., Shows, E. B., & Wente, S. R. (2007) · Science · doi:10.1126/science.1142204 · Cited by 548
Metadata
- Authors
- Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Centers for Disease Control and Prevention (US)
- Lyon 1 Université (FR)
- Corresponding author
- Basler, Christopher F.
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-06
- Volume
- 80
- Issue
- 11
- Pages
- 5156-5167
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2136920638
- Cited by
- 463
- References
- 61
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 15 · 2023: 21 · 2022: 10 · 2021: 22 · 2020: 23 · 2019: 19 · 2018: 20 · 2017: 33 · 2016: 29 · 2015: 53 · 2014: 30 · 2013: 13 · 2012: 20
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ellison Medical Foundation
- Institut National de la Santé et de la Recherche Médicale
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- Ebola virus, VP24, interferon signaling, interferon-gamma signaling, type I interferon, viral evasion of innate immunity, antiviral state, protein-protein interaction, virulence factors
- MeSH terms
- Animals, Cell Line, Chlorocebus aethiops, Vero Cells, Viral Proteins, Signal Transduction, alpha Karyopherins, Ebolavirus, STAT1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation. https://app.cochat.ai/papers/10.1128/jvi.02349-05
- The paper
- Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006). Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation. Journal of Virology. https://doi.org/10.1128/jvi.02349-05
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.